Skip to main content

Year: 2020

Praxis Precision Medicines Provides Update On PRAX-114 IND Submission For The Treatment Of Major Depressive Disorder

– Praxis expects to initiate Phase 2/3 clinical trial for PRAX-114 in MDD in 1H21 –CAMBRIDGE, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance, today announced that it has received comments from the U.S. Food and Drug Administration (FDA) on the full clinical hold of its Investigational New Drug (IND) submission for PRAX-114 for the treatment of major depressive disorder (MDD).The IND for PRAX-114 was placed on clinical hold by the FDA pending the resolution of certain non-clinical pharmacology and toxicology matters. In its comment letter, the FDA proposed that the Company conduct further toxicological...

Continue reading

Raute toimittaa uusinta levynkorjausteknologiaa Pohjois-Amerikan vaneriteollisuudelle

RAUTE OYJ LEHDISTÖTIEDOTE 17.11.2020RAUTE TOIMITTAA UUSINTA LEVYNKORJAUSTEKNOLOGIAA POHJOIS-AMERIKAN VANERITEOLLISUUDELLE Raute on tuonut markkinoille täysin automaattiset uuden ja ainutlaatuisen levynkorjausaseman sekä uuden sukupolven levynkorjauslinjan. Levyn korjauksen automatisoinnin myötä vanerintuotannon kustannustehokkuus kasvaa samalla kun levyjen loppulaadun tasaisuus ja eri laatujen hallittavuus paranevat. Uusimmat levynkorjausratkaisut ovat herättäneet suurta kiinnostusta ennen kaikkea Pohjois-Amerikassa, mistä osoituksena ovat saadut kaupat kahdelle eri asiakkaalle Pohjois-Amerikkaan toimitettavista levynkorjauslinjasta ja -asemista. Tilatut koneet ja laitteet toimitetaan vuoden 2021 loppuun mennessä ja ne suunnitellaan ja valmistetaan pääosin Rauten tuotantoyksikössä Nastolassa. Lisäksi osa työstä tehdään myös Rauten yksikössä...

Continue reading

Raute delivers state-of-the-art panel repairing technology for North America’s plywood industry 

RAUTE CORPORATION PRESS RELEASE 17 NOVEMBER 2020RAUTE DELIVERS STATE-OF-THE-ART PANEL REPAIRING TECHNOLOGY FOR NORTH AMERICA’S PLYWOOD INDUSTRY Raute has launched a new and unique panel repair station and next-generation panel repairing line. Automatic panel repairing increases the cost efficiency of plywood production, ensures that the final quality of the panels is more uniform and makes it easier to control the various panel grades. Raute’s latest panel repairing solutions have aroused great interest, particularly in North America, resulting in orders for panel repair stations and a panel repairing line to be delivered to two different customers in North America. The ordered machinery and equipment will be delivered by the end of 2021. The equipment will be engineered and manufactured mainly in Raute’s production unit in Nastola, Finland....

Continue reading

[2019-2026], Host Cell Contaminant Testing Market Size, Share, Growth, Trends, Revenue, Analysis, Competitive Landscape, Forecast

Pune, India, Nov. 17, 2020 (GLOBE NEWSWIRE) — The global Host Cell Contaminant Testing Market will derive growth from the massive investments in product R&D. Recent discoveries that have indicated the properties to treat severe diseases such as cancer will bode well for market growth. According to a report by Fortune Business Insights. The market will benefit from the increasing healthcare budgets across the world. Host cell contaminant testing is the study of biologics from living sources such as bacteria, yeasts, and fungi. The process is used for research and development process in critical diseases such as cancer. North America is projected to emerge dominant in the coming years.  The increasing number of research activities will have a huge impact on the growth of the regional market.Industry Developments:August 2019:...

Continue reading

Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program

AMSTERDAM, Nov. 17, 2020 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) (“Field Trip”), a global leader in the development and delivery of technology-enabled psychedelic therapies, announced today that it has entered into a lease and plans to open a Field Trip Health Center in Amsterdam, Netherlands. Located at Piet Heinkade 55 overlooking the IJhaven River, the 665 sqm (7158 sqft) Amsterdam location will be the first Field Trip Health center focused on therapeutic use of psychedelics using legal truffles. Field Trip expects to begin accepting people interested in participating in its truffle programs in December 2020, and the Netherlands location of Field Trip Health is expected to open in March 2021.“Globally, we are in the midst of a mental health crisis, and The Netherlands is no exception....

Continue reading

Vibra Healthcare and Ernest Health Select Inovalon’s EASE® All-Payer Solution

BOWIE, Md., Nov. 17, 2020 (GLOBE NEWSWIRE) — Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced separate 5-year agreements with two prominent post-acute care providers, Vibra Healthcare and Ernest Health. Inovalon’s services will enable greater administrative efficiency and increased accuracy of payment processes undertaken by Vibra Healthcare’s 34 facilities and Ernest Health’s 30 facilities, which offer inpatient rehabilitation hospital services, long-term acute care hospital services and skilled nursing across a combined 19 states.Healthcare providers must maintain the highest standards in managing the many data submissions and processing pertaining to their delivery of clinical care, associated claims, payments and receivables from commercial payers and Medicare,...

Continue reading

Form 8.3 – AXA INVESTMENT MANAGERS: deali Codemasters Group Holdings plc

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

Continue reading

Report [2019-2026], Smart Pills Market Size, Share, Growth, Trends, Competitive Analysis, Revenue, Driving Factors and Forecast

Pune, India, Nov. 17, 2020 (GLOBE NEWSWIRE) — The global smart pills market size is set to gain traction from the increasing usage of these non-invasive devices for the diagnosis of gastrointestinal disorders and cancer. They can ever replace the traditional diagnostic techniques such as endoscopy. The report further states that smart pills include chemical sensor, pH, or biosensor. When swallowed, they can travel along the gastrointestinal tract for capturing images.  North America is likely to remain in the dominant position throughout the near future by earning the largest smart pills market share.Smart Pills Industry Developments:In January 2019, Proteus Digital Health launched its first digital cancer chemotherapy pill in the market with an aim to help oncologists track treatment effectiveness and adherence in the cancer patients.In...

Continue reading

U.K. Enterprises Mounted Successful Technology Rollouts for Homebound Employees to Meet COVID-19 Lockdowns

LONDON, Nov. 17, 2020 (GLOBE NEWSWIRE) — Faced with the COVID-19 outbreak and new regulations to control it in the second quarter of 2020, large and small businesses in the U.K. ably implemented technology transformations that allowed thousands of employees to work from home, according to a new report published today by Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm.The 2020 ISG Provider Lens™ Digital Workplace of the Future – Services & Solutions report for the U.K. found most organizations smoothly provided remote workers with the devices, bandwidth and collaboration tools they needed. The bigger issues raised by the transition were security and change management, the report says.Public and private-sector enterprises wanted to ensure endpoints were secure and employees—especially...

Continue reading

Thryv, Inc. to Participate in Stephens Annual Investment Conference 2020

Dallas, Nov. 17, 2020 (GLOBE NEWSWIRE) — Thryv Holdings, Inc. (NASDAQ:THRY), the provider of Thryv® software, the end-to-end client experience platform for small businesses, today announced that CEO and President Joe Walsh will participate in a virtual fireside chat discussion at the Stephens Annual Investment Conference 2020 on November 19 at 3 p.m. ET.A live webcast of the Stephens conference presentation will be available on the Thryv investor relations website at investor.thryv.com. An archived replay will be made available for a limited time at the same location following the event. About Thryv Holdings, Inc.The company owns the easy-to-use Thryv® end-to-end customer experience software built for small business that helps over 40,000 SaaS clients with the daily demands of running a business. With Thryv, they can get the job,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.